A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors
Memorial Sloan Kettering Cancer Center · NCT05574127
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 65+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 150
- US sites recruiting
- 1
- Study start
- October 6, 2022
- Record last updated
- August 27, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to find out if a psychotherapy method called behavioral activation (BA) can be successfully delivered by telephone or videoconference (remotely) and can effectively treat depression in Older Adult Cancer Survivors (OACS)
Being studied: Behavioral Activation; Supportive Psychotherapy
Conditions: Survivorship
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Phase I
- As per self-report or medical record, ≥65 years old
- As per self-report or medical record, has a history of cancer
- As per medical record and/or clinician confirmation:
- a patient in MSK Survivorship Clinics AND/OR
- no evidence of disease (NED) AND/OR
- 6 months or more post-treatment (patients on maintenance hormonal therapies are eligible)
- Fluent in English, as per self-reported fluency of "well" or "very well"*
- As per self-report, able to communicate over video-conference and/or phone for sessions
- Elevated score on the PHQ-9: ≥5 (N/A for Training Case participants)
- Received a Blessed Orientation-Memory-Concentration Scale (BOMC) score of ≤ 11 (N/A for Training Case participants)
Phase II
- As per self-report or medical record, ≥18 years old
- Fluent in English, as per self-reported fluency of "well" or "very well"*
- As per self-report or medical record, has a history of cancer
- Elevated score on the PHQ-9: ≥5
- Received a Blessed Orientation-Memory-Concentration Scale (BOMC) score of ≤ 11 (N/A for Training Case participants)
Note. The eligibility criteria for Phase II allows inclusion of younger participants and those receiving active treatment due to the theoretical rationale that a single-session intervention will remove certain barriers that are believed to exist for these groups in receiving the longer, 10-session intervention.
Exclusion Criteria
Phase I
- As per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of > 0 on item 9 of the PHQ-9, they will be referred to study PI for further evaluation. They will be excluded from participation in this study if the PI determines they would be appropriate for a higher level of care than BA may be able to provide.
- As per self-report or as documented in the medical record, current untreated (e.g., no medication, no therapy) major psychotic disorder (schizotypal personality disorder, schizophreniform disorder, schizoaffective disorder). Patients diagnosed with a major psychiatric disorder will be reviewed by the study PI to determine eligibility prior to consent.
- As per self-report or medical record, currently taking antidepressant medication for \< 3 month
- As per medical record, patient has impaired decision-making capacity
Phase II
- As per PI determination, requires a higher level of care for current active suicidal ideation than current protocol is able to provide. If a participant receives a score of > 0 on item 9 of the PHQ-9, they will be referred to study PI for further evaluation. They will be excluded from participation in this study if the PI determines they would be appropriate for a higher level of care than BA may be able to provide.
- As per self-report or medical record, current weekly psychotherapy or currently taking an antidepressant for \<3 months.
- As per medical record, patient has impaired decision-making capacity
- Language verification: Prior to enrollment, patients will be asked the following two questions by research staff to verify English fluency necessary for participation in the study:
- How well do you speak English? (must respond "Well" or "Very well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
- What is your preferred language for healthcare? (must respond English)
Recruiting US locations
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, NY 10065
Site contact: Rebecca Saracino, PhD · 646-888-0263
Study contacts (from the official record)
- Rebecca Saracino, PhD · 646-888-0263 · jamesr@mskcc.org
- Christian Nelson, PhD · 646-888-0030 · nelsonc@MSKCC.ORG
Similar studies in New York
All mental health studies in New York →- RecruitingHealthy volunteersPhase 1/Phase 2
Study of Cannabidiol and Neuroimaging on Stress
Icahn School of Medicine at Mount Sinai
- Location
- New York, NY
- Eligibility basics
- Ages 18–25
- RecruitingHealthy volunteersPhase 1
MDMA-Assisted Therapy for Mental Healthcare Providers
Rachel Yehuda
- Location
- New York, NY
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Anxiety During Abstinence in AUD
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 21–55
- RecruitingHealthy volunteers
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
Ponce Medical School Foundation, Inc.
- Location
- Commack, NY + 6 other US sites
- Eligibility basics
- Ages 21–100